Samuel M. Moskowitz

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 4 papers. Top paper: “Triple Therapy for Cystic Fibrosis Phe508del –Gating and –Residual Function Genotypes”.

Triple Therapy for Cystic Fibrosis Phe508del –Gating and –Residual Function Genotypes

New England Journal of Medicine(2021)10.1056/nejmoa2100665

N/A

7.1DataRank · unranked

277 citations

Marcus Mall, Antonio Álvarez, Carla Colombo, Karin M. de Winter‐de Groot, Isabelle Fajac +17 more

Polymyxin-Induced Lipid A Deacylation in Pseudomonas aeruginosa Perturbs Polymyxin Penetration and Confers High-Level Resistance

ACS Chemical Biology(2018)10.1021/acschembio.7b00836

N/A

2.4DataRank · unranked

65 citations

Tony Velkov, Yan Zhu, Kade D. Roberts, Anton P. Le Brun, Seong Hoong Chow +5 more

Neutrophil Extracellular Trap (NET)-Mediated Killing of Pseudomonas aeruginosa: Evidence of Acquired Resistance within the CF Airway, Independent of CFTR

UNC Libraries(2020)10.17615/rk4n-6503

N/A

0DataRank · unranked

0 citations

Kenneth C. Malcolm, Michael L. Vasil, Jennifer L. Taylor‐Cousar, Katie R. Poch, Jerry A. Nick +8 more

Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation: A Phase 3b, Randomized, Placebo-controlled Study

American Journal of Respiratory and Critical Care Medicine(2022)10.1164/rccm.202202-0392oc

N/A

0DataRank · unranked

141 citations

Rossa Brugha, Silvia Gärtner, Julian Legg, Alexander Mœller, Pedro Mondéjar-López +19 more